what are the two glp 1 drugs GLP-1 all approved for glucose control in type 2 diabetes (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, and obesity. None MCT2D | The Benefits of

Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)

Adv Pharm Bull

Energy and recovery may improve within 24 weeks, while visible skin benefits like clarity and glow usually take 612 weeks

Thnh phn: Glutathione 1650mg, EGF t nhau thai nga, vitamin C, vitamin E, alpha lipoic acid., u im: i tng s dng: Cch s dng: Lu : Gi tham kho: 760.000 VN/hp 90 vin